Katsanos, Aristeidis H.

Neurological manifestations and implications of COVID-19 pandemic

Tsivgoulis, G., Palaiodimou, L., Katsanos, A. H., Caso, V., Köhrmann, M., Molina, C., Cordonnier, C., Fischer, U., Kelly, P., Sharma, V. K., et al. (2020) · Therapeutic Advances in Neurological Disorders

Long-Term Effects of COVID-19COVID-19 Clinical Research Studies

Cited by 145

Timing of Recanalization and Functional Recovery in Acute Ischemic Stroke

Tsivgoulis, G., Saqqur, M., Sharma, V. K., Brunser, A., Eggers, J., Mikulik, R., Katsanos, A. H., Sergentanis, T. N., Vadikolias, K., Perren, F., et al. (2020) · Journal of Stroke

Acute Ischemic Stroke ManagementCerebrovascular and Carotid Artery Diseases

Cited by 68

GLP-1 receptor agonists in diabetes for stroke prevention: a systematic review and meta-analysis

Malhotra, K., Katsanos, A. H., Lambadiari, V., Goyal, N., Palaiodimou, L., Kosmidou, M., Krogias, C., Alexandrov, A. V., & Tsivgoulis, G. (2020) · Journal of Neurology

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 65

Risk of major adverse cardiovascular events and stroke associated with treatment with GLP-1 or the dual GIP/GLP-1 receptor agonist tirzepatide for type 2 diabetes: A systematic review and meta-analysis

Stefanou, M.-I., Theodorou, A., Malhotra, K., Aguiar de Sousa, D., Katan, M., Palaiodimou, L., Katsanos, A. H., Koutroulou, I., Lambadiari, V., Lemmens, R., et al. (2024) · European Stroke Journal

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 60

Risk of major adverse cardiovascular events and all-cause mortality under treatment with GLP-1 RAs or the dual GIP/GLP-1 receptor agonist tirzepatide in overweight or obese adults without diabetes: a systematic review and meta-analysis

Stefanou, M.-I., Palaiodimou, L., Theodorou, A., Safouris, A., Fischer, U., Kelly, P. J., Dawson, J., Katan, M., Katsanos, A. H., Lambadiari, V., et al. (2024) · Therapeutic Advances in Neurological Disorders

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 36

Inflammatory Bowel Disease and Patients With Mental Disorders: What Do We Know?

Fousekis, F. S., Katsanos, A. H., Kourtis, G., Saridi, M., Albani, E., Katsanos, K. H., & Christodoulou, D. K. (2021) · Journal of Clinical Medicine Research

Inflammatory Bowel DiseaseGut microbiota and health

Cited by 28